Managing the climacteric.
HRT taken for a sufficient duration may reduce the occurrence of osteoporosis and of cardiovascular disease by up to 50% and possibly also reduce incidence and lessen severity of Alzheimer's disease. Nevertheless, it is often only prescribed when women request it to relieve climacteric symptoms. Furthermore, many physicians prescribe it for only limited periods of time and few are willing to prescribe it to women in their sixties. As with any long-term prevention strategy, the uptake of HRT is much lower than the prescription rate, since the medication is often abandoned due to side effects or due to lack of motivation. But HRT is often abandoned also due to fear of cancer. While physicians may be aware of some beneficial effects of HRT, they often have no time to inform their patients of them. Alternatively, some of the beneficial effects such as cardioprotection or a reduced incidence of Alzheimer's may be less known. Likewise, HRT-related side effects or risks such as breast cancer or thromboembolic diseases should be discussed prior to HRT prescription. Women need to be informed about these potential risks, and this should be done by their physician. Surveys have shown that many women feel that they receive insufficient information from their physician. The quality of the relationship between physician and patient probably has a large influence on HRT acceptance, but very few studies have been conducted to assess specifically factors influencing the prescription and the continuation rate of HRT. Simple strategies may be among the most effective ones; these include listening to patients' fears, complaints and questions, and taking the time to answer them. The role of a practice nurse in such a setting may be also very important.
Rozenberg
S
S
Interdisciplinary Group on Osteoporosis, St. Peter Hospital, Free Universities of Brussels, Belgium.
Vandromme
J
J
Kroll
M
M
Vasquez
J B
JB
D001294:Attitude to Health; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008593:Menopause / Q000187:drug effects / Q000523:psychology; D010349:Patient Compliance; D010353:Patient Education as Topic